Biotechnology Deals: Key Strategies for M&A, Financings, and Partnerships in the Biotech Industry
Inside the Minds: Biotechnology Deals is an authoritative, insider's perspective on the issues surrounding biotech deals, including mergers and acquisitions, collaborations, and the future of doing successful deals. Featuring lawyers, CEOs of funded biotech companies, and venture capitalists who invest in them, this book provides a broad, yet comprehensive overview of the art of doing successful deals from the experts themselves. From finding and capitalizing on opportunities to completing the deal, these authors articulate the finer points around doing biotech deals now and what will hold true into the future. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today as experts offer up their thoughts around the keys to success within this fascinating area.About Inside the Minds: Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book.This book is by: Lee R. Brettman, M.D., FACP, Dynogen Pharmaceuticals, Inc.—“Successful Strategies for Biotech Deals” Manish N Chapekar, Montreux Equity Partners—“Building Successful Biotech Deals” Daniel Devine, Acceptys, Inc.—“The Art of the Deal” Mark I. Gruhin, Schmeltzer, Aptaker & Shepard, PC—“Mergers and Acquisitions, Collaborations, and Partnerships” James T. Gunton, NJTC Venture Fund—“Strategies for Successful Deals” Johnny Humphreys, Gen Prime—“Finding Success in Biotech” Roland H. Johnson, Piedmont Pharmaceuticals LLC—“Making Your Way Through Biotech Dealings” Thomas G. Klopack, Self Employed, Former CEO of Aclara Biosciences—“Keys to Success in Biotechnology” Gerard J. McGarrity, Ph.D., Intronn Inc.—“Successful Biotech Deals” Mark Schwartz , Ph.D., Bayhill Therapeutics—“Biotech Deal Strategies“ Abhi-Shek Jain, WTP Capital, LLC—“Secrets to Success” Alexis V. Lukianov, NuVasive, Inc.—“Finding and Capitalizing on Opportunities”
What people are saying - Write a review
We haven't found any reviews in the usual places.
analysis Aspatore assets biotech company Biotech Deals biotechnology biotechnology company build business development colleague business development professional buyer C-Level chief executive officer clinical trials company's compound contract corporate discussions documents drug due diligence early-stage entrepreneur evaluate example Financial Modeling focus focused given transaction goals going growth Gruhin identify IDEXX Laboratories impact important industry intellectual property internal investors involved issues lead long-term look major management team marketplace merger and acquisition milestones million multiple needs negotiations Novartis objectives operational colleagues operational groups opportunities organization partnership party patents Pfizer pharmaceutical companies Phase poison ivy potential partner president regulatory relationship revenue risk role royalties scientific selling biotech significant small company stage strategic structure successful deal term sheet therapeutic products understanding upfront payments usually valuation value creation Venture Capital venture capitalists Vertex Pharmaceutical win-win